home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops

Search  -  prev / next

 
 

Regulatory Affairs: Part I: The IND Phase, Part II: The CTD/NDA Phase

 
  April 23, 2008

Others

 
     
 
Drug Information Association, Massachusetts College of Pharmacy, Boston, MA, USA
Aug 4 2008


This course combines the two three-day courses into one extended five-day offering.  It describes the regulatory background of the IND and NDA and provides an overview of the requirements and recommendations for preparing and managing these applications. Please note that this August offering is a 5 day version of Regulatory Affairs: Part I: The IND Phase and Part II: The CTD/NDA Phase.
 
 
Organized by: Drug Information Association
Invited Speakers: 1) Roger W CroswellPresidentRegulatory Consulting Services, LLC

United States.

2) Michael R. Hamrell, PhD, RAC President MORIAH ConsultantsUnited States.  

3) Drusilla L. Scott, PhD, RACVP, Regulatory AffairsCempra PharmaceuticalsUnited States.

 
Deadline for Abstracts: -
 
Registration: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16065&eventType=Training%20Course
E-mail: dia@diahome.org
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2008 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.